Clin2
NCT03001973Likely a fitRecruiting

Study of Chinese lupus kidney inflammation evidence

Lupus Nephritis

Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.

This trial is for people who have lupus nephritis, which means lupus affecting the kidneys. It aims to gather high-quality evidence that may help improve how this condition is understood and cared for.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
5,000 people
Ages
14 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with lupus nephritis (lupus affecting the kidneys)
  • You are currently able to participate in a study based on that diagnosis

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05268289Recruiting· Phase 2
Trial for lupus kidney inflammation using LNP023

This Phase 2 study tests whether LNP023 can improve outcomes and safety in people with active lupus nephritis (lupus-related kidney inflammation), class III or IV. It may help by targeting the ongoing immune activity that is damaging the kidneys.

Phoenix, Arizona
NCT06167174Recruiting
Looking for markers to predict lupus kidney treatment response

This study is looking for biomarkers (clues in your blood, urine, or tissue) that can help predict how well lupus nephritis (kidney inflammation caused by lupus) responds to treatment. It focuses on people who have active kidney disease and are either starting treatment or have been on a stable treatment for at least a month.

Beijing
NCT07505576Not yet recruiting
Antibodies and lupus kidney disease activity study

This study looks at whether a specific antibody (anti-alpha-actinin) in the blood is linked to active lupus kidney disease. It may help doctors better understand and monitor kidney problems in people with lupus.

NCT07393451Not yet recruiting· Phase 2
Study of SIM0278 for active lupus nephritis

This trial tests a new drug called SIM0278 for people with active lupus nephritis (kidney inflammation caused by lupus). It aims to see if adding this drug to standard treatment is safe and helpful for controlling the disease.

Beijing
NCT07767188Not yet recruiting· Phase 3
Adding obinutuzumab to standard therapy for active lupus nephritis

This trial tests whether adding the drug obinutuzumab to standard therapy (mycophenolate and steroids) helps control lupus-related kidney inflammation better than standard therapy alone. It might reduce kidney damage and improve outcomes for people with active lupus nephritis.

Fuzhou, Fujian
NCT07666711Recruiting
Kidney biomarker study for lupus patients

This study aims to find better ways to detect kidney problems in people with lupus by testing blood and urine samples. If you have lupus, you may help researchers improve how kidney disease is diagnosed and monitored.

Oslo, Oslo

Hear when a new Lupus Nephritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.